Leukemia Clinical Trials

Showing 2921-2940 of 5,235 trials

Improving Palliative Care Access Through Technology

NCT04969484

This project will focus on developing, optimizing and pilot-testing a multi-component Improving Access Through Technology (ImPAcTT) intervention that leverages existing telehealth technologies to provide staff education; family outreach, engagement and support; care coordination; and resident symptom management and facilitation of goals-of-care discussion.

TelehealthPalliative Care

University of Utah81 participantsStarted Feb 2018

San Francisco, California, United States • Salt Lake City, Utah, United States

TERMINATEDPhase 2

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

NCT00449761

This study will evaluate the efficacy and safety of LBH589B in adult patients with chronic myeloid leukemia who are in accelerated phase or blast phase (blast crisis) with resistant disease following treatment with at least two BCR-ABL tyrosine kinase inhibitors

Leukemia, Myeloid, Chronic

Novartis Pharmaceuticals27 participantsStarted Feb 2007

Duarte, California, United States • Aurora, Colorado, United States • Denver, Colorado, United States +23 more locations

Improving Palliative Care Access Through Technology

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

Related Searches

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients

Pembrolizumab + CVA21 in Advanced NSCLC

B-cell Chronic Lymphoid Malignancies Markers

AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients

A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia

The Correlation Between Fasicitis Plantaris and Hallux Rigidus

A Study of AK-01 (LY3295668) in Solid Tumors

The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line

Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation

Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia

Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients

Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances

Treatment of Acute, Unstable Chest Wall Injuries

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer